Extended anticoagulation after venous thromboembolism: should it be done?

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorFERNANDES, Caio J.
dc.contributor.authorCALDERARO, Daniela
dc.contributor.authorPILOTO, Bruna
dc.contributor.authorHOETTE, Susana
dc.contributor.authorJARDIM, Carlos Vianna Poyares
dc.contributor.authorSOUZA, Rogerio
dc.date.accessioned2019-11-06T18:46:07Z
dc.date.available2019-11-06T18:46:07Z
dc.date.issued2019
dc.description.abstractMost physicians understand venous thromboembolism (VTE) to be an acute and time-limited disease. However, pathophysiological and epidemiological data suggest that in most patients VTE recurrence risk is not resolved after the first 6 months of anticoagulation. Recurrence rates are high and potentially life-threatening. In these cases, it would make sense to prolong anticoagulation for an undetermined length of time. However, what about the bleeding rates, induced by prolonged anticoagulation? Would they not outweigh the benefit of reducing the VTE recurrent risk? How long should anticoagulation be continued, and should all patients suffering from VTE be provided with extended anticoagulation? This review will address the most recent data concerning extended anticoagulation in VTE secondary prophylaxis. The reviews of this paper are available via the supplementary material section.eng
dc.description.indexMEDLINEeng
dc.identifier.citationTHERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, v.13, article ID 1753466619878550, 13p, 2019
dc.identifier.doi10.1177/1753466619878556
dc.identifier.eissn1753-4666
dc.identifier.issn1753-4658
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/33954
dc.language.isoeng
dc.publisherSAGE PUBLICATIONS LTDeng
dc.relation.ispartofTherapeutic Advances in Respiratory Disease
dc.rightsopenAccesseng
dc.rights.holderCopyright SAGE PUBLICATIONS LTDeng
dc.subjectdeep vein thrombosiseng
dc.subjectdirect oral anticoagulantseng
dc.subjectextended anticoagulationeng
dc.subjectprovokedeng
dc.subjectpulmonary embolismeng
dc.subjecttreatmenteng
dc.subjectunprovokedeng
dc.subjectvenous thromboembolismeng
dc.subject.otherdeep-vein thrombosiseng
dc.subject.otherintensity warfarin therapyeng
dc.subject.otherpulmonary-embolismeng
dc.subject.othersecondary preventioneng
dc.subject.other1st episodeeng
dc.subject.otherlong-termeng
dc.subject.otherriskeng
dc.subject.otheraspirineng
dc.subject.othercancereng
dc.subject.otherrecurrenceeng
dc.subject.wosRespiratory Systemeng
dc.titleExtended anticoagulation after venous thromboembolism: should it be done?eng
dc.typearticleeng
dc.type.categoryrevieweng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.citation.scopus9
hcfmusp.contributor.author-fmusphcCAIO JULIO CESAR DOS SANTOS FERNANDES
hcfmusp.contributor.author-fmusphcDANIELA CALDERARO
hcfmusp.contributor.author-fmusphcBRUNA MAMPRIM PILOTO
hcfmusp.contributor.author-fmusphcSUSANA HOETTE
hcfmusp.contributor.author-fmusphcCARLOS VIANA POYARES JARDIM
hcfmusp.contributor.author-fmusphcROGERIO DE SOUZA
hcfmusp.description.articlenumber1753466619878550
hcfmusp.description.volume13
hcfmusp.origemWOS
hcfmusp.origem.pubmed31558116
hcfmusp.origem.scopus2-s2.0-85072693307
hcfmusp.origem.wosWOS:000487953900001
hcfmusp.publisher.cityLONDONeng
hcfmusp.publisher.countryENGLANDeng
hcfmusp.relation.referenceAgnelli G, 2013, NEW ENGL J MED, V368, P699, DOI 10.1056/NEJMoa1207541eng
hcfmusp.relation.referenceAlbertsen IE, 2018, CIRCULATION, V138, P2591, DOI 10.1161/CIRCULATIONAHA.118.036548eng
hcfmusp.relation.referenceAndreozzi GM, 2015, CIRCULATION, V132, P1891, DOI 10.1161/CIRCULATIONAHA.115.016930eng
hcfmusp.relation.referenceBaglin T, 2003, LANCET, V362, P523, DOI 10.1016/S0140-6736(03)14111-6eng
hcfmusp.relation.referenceBARRITT DW, 1960, LANCET, V1, P1309eng
hcfmusp.relation.referenceBauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903eng
hcfmusp.relation.referenceBecattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238eng
hcfmusp.relation.referenceBlondon M, 2015, CIRCULATION, V132, P1856, DOI 10.1161/CIRCULATIONAHA.115.019310eng
hcfmusp.relation.referenceBova C, 2016, THROMB RES, V139, P22, DOI 10.1016/j.thromres.2016.01.005eng
hcfmusp.relation.referenceBrighton TA, 2012, NEW ENGL J MED, V367, P1979, DOI 10.1056/NEJMoa1210384eng
hcfmusp.relation.referenceBuller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638eng
hcfmusp.relation.referenceFernandes CJCD, 2017, J BRAS PNEUMOL, V43, P403, DOI [10.1590/S1806-37562017000060002, 10.1590/s1806-37562017000060002]eng
hcfmusp.relation.referenceFernandes CJCD, 2016, J BRAS PNEUMOL, V42, P146, DOI [10.1590/S1806-37562016042020068, 10.1590/S1806-37562016000000068]eng
hcfmusp.relation.referenceCimminiello C, 2017, INTERN EMERG MED, V12, P1291, DOI 10.1007/s11739-017-1714-9eng
hcfmusp.relation.referenceCouturaud F, 2016, EUR RESPIR J, V47, P1313, DOI 10.1183/13993003.00212-2016eng
hcfmusp.relation.referenceCouturaud F, 2015, JAMA-J AM MED ASSOC, V314, P31, DOI 10.1001/jama.2015.7046eng
hcfmusp.relation.referencede Moerloose P, 2001, Semin Vasc Med, V1, P89, DOI 10.1055/s-2001-14545eng
hcfmusp.relation.referenceDouketis J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d813eng
hcfmusp.relation.referenceDouketis J, 2010, ANN INTERN MED, V153, P523, DOI 10.7326/0003-4819-153-8-201010190-00009eng
hcfmusp.relation.referenceEichinger S, 2008, ARCH INTERN MED, V168, P1678, DOI 10.1001/archinte.168.15.1678eng
hcfmusp.relation.referenceEichinger S, 2010, CIRCULATION, V121, P1630, DOI 10.1161/CIRCULATIONAHA.109.925214eng
hcfmusp.relation.referenceFernandes C, 2018, J BRAS PNEUMOL, V44, P180eng
hcfmusp.relation.referenceFernandes CJ, 2019, RESPIRATION, V98, P253, DOI 10.1159/000501342eng
hcfmusp.relation.referenceFernandes CJ, 2019, EUR RESPIR REV, V28, DOI 10.1183/16000617.0119-2018eng
hcfmusp.relation.referenceFrancis CW, 2015, J THROMB HAEMOST, V13, P1028, DOI 10.1111/jth.12923eng
hcfmusp.relation.referenceGandara E, 2013, THROMB HAEMOSTASIS, V110, P1172, DOI 10.1160/TH13-06-0488eng
hcfmusp.relation.referenceGavilanes-Oleas FA, 2018, CLINICS, V73, DOI 10.6061/clinics/2018/e216eng
hcfmusp.relation.referenceJiang QJ, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00876eng
hcfmusp.relation.referenceKearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422eng
hcfmusp.relation.referenceKearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201eng
hcfmusp.relation.referenceKearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026eng
hcfmusp.relation.referenceKearon C, 2015, ANN INTERN MED, V162, P27, DOI 10.7326/M14-1275eng
hcfmusp.relation.referenceKERNOHAN RJ, 1966, LANCET, V1, P621eng
hcfmusp.relation.referenceKhorana AA, 2018, J THROMB HAEMOST, V16, P1891, DOI 10.1111/jth.14219eng
hcfmusp.relation.referenceKyrle PA, 2004, NEW ENGL J MED, V350, P2558, DOI 10.1056/NEJMoa032959eng
hcfmusp.relation.referenceLaporte S, 2008, CIRCULATION, V117, P1711, DOI 10.1161/CIRCULATIONAHA.107.726232eng
hcfmusp.relation.referenceLyman GH, 2015, J CLIN ONCOL, V33, P654, DOI 10.1200/JCO.2014.59.7351eng
hcfmusp.relation.referenceMcrae S, 2006, LANCET, V368, P371, DOI 10.1016/S0140-6736(06)69110-1eng
hcfmusp.relation.referenceMukai M, 2018, J CARDIOL, V72, P89, DOI 10.1016/j.jjcc.2018.02.011eng
hcfmusp.relation.referencePalareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444eng
hcfmusp.relation.referencePiazza G, 2015, CLIN CHEM, V61, P313, DOI 10.1373/clinchem.2014.234088eng
hcfmusp.relation.referencePrandoni P, 2002, BLOOD, V100, P3484, DOI 10.1182/blood-2002-01-0108eng
hcfmusp.relation.referencePrandoni P, 2007, HAEMATOL-HEMATOL J, V92, P199, DOI 10.3324/haematol.10516eng
hcfmusp.relation.referencePrins MH, 2018, BLOOD ADV, V2, P788, DOI 10.1182/bloodadvances.2018017160eng
hcfmusp.relation.referencePuurunen MK, 2016, THROMB RES, V145, P27, DOI 10.1016/j.thromres.2016.06.033eng
hcfmusp.relation.referenceRaskob GE, 2014, THROMB HAEMOSTASIS, V112, P843, DOI 10.1160/TH14-08-0671eng
hcfmusp.relation.referenceRaskob GE, 2018, NEW ENGL J MED, V378, P615, DOI 10.1056/NEJMoa1711948eng
hcfmusp.relation.referenceRidker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029eng
hcfmusp.relation.referenceSchulman S, 2013, NEW ENGL J MED, V368, P709, DOI 10.1056/NEJMoa1113697eng
hcfmusp.relation.referenceSimes J, 2014, CIRCULATION, V130, P1062, DOI 10.1161/CIRCULATIONAHA.114.008828eng
hcfmusp.relation.referenceSTEELE P, 1980, LANCET, V2, P1328eng
hcfmusp.relation.referenceTosetto A, 2012, J THROMB HAEMOST, V10, P1019, DOI 10.1111/j.1538-7836.2012.04735.xeng
hcfmusp.relation.referenceTurpie AGG, 2017, RES PRACT THROMB HAE, V1, P1eng
hcfmusp.relation.referenceVenker BT, 2017, J ARTHROPLASTY, V32, P645, DOI 10.1016/j.arth.2016.09.033eng
hcfmusp.relation.referenceVolschan A, 2004, ARQ BRAS CARDIOL S1, V83, P1eng
hcfmusp.relation.referenceWeitz JI, 2017, NEW ENGL J MED, V376, P1211, DOI 10.1056/NEJMoa1700518eng
hcfmusp.relation.referenceYoung AM, 2018, J CLIN ONCOL, V36, P2017, DOI 10.1200/JCO.2018.78.8034eng
hcfmusp.scopus.lastupdate2024-06-09
relation.isAuthorOfPublication8d16de87-4cf2-475c-b186-0eb934027217
relation.isAuthorOfPublicationd9e02a87-4fb1-48da-9f5b-68396a8d2b36
relation.isAuthorOfPublication55d7369e-8f9d-459a-800d-72a986a49455
relation.isAuthorOfPublication6a008c52-4bcd-4b06-a28a-de2d2931b1a5
relation.isAuthorOfPublication2f44c5a4-e651-4540-be6e-69fccf234119
relation.isAuthorOfPublication502d5aeb-c5a4-4275-8c07-02d25223d6d1
relation.isAuthorOfPublication.latestForDiscovery8d16de87-4cf2-475c-b186-0eb934027217
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
art_FERNANDES_Extended_anticoagulation_after_venous_thromboembolism_should_it_be_2019.PDF
Tamanho:
379.77 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)